Despite an over 80% rise in less than 2 months, Motilal Oswal says buy this newly-listed stock - Reason, target price
A ipo & listings development with market-wide reach.
· LiveMint Markets
Molbio Diagnostics share price was listed on the Indian bourses on 17 August this year. At the current market price of ₹1,475.50, it is up 83% from its IPO price of ₹807 in less than two months.
Key facts
- Dates in focus
- 17 August
The analysis
Listing activity is a read on risk appetite — a hot primary market usually means a confident secondary one.
Because the driver here is macro rather than company-specific, the read-through is to index-level positioning rather than to any single name — correlations tend to rise when the whole market faces the same signal.
Market context
- This is a market-wide development — its reach goes beyond any single stock.
Related coverage
Vishal Nirmiti shares list at 2% discount over IPO price on NSE, BSE
Reliance shares may be a cheaper way to buy Jio Platforms after its listing
Vodafone Idea zooms 12% after FPO sees 6x subscription; focus shifts to allotment, listing
PSP Projects share gains 4% on launching Rs 244-crore QIP
Indus Towers gains 4% after CLSA upgrade to #39;buy#39; on Voda Idea FPO